Baxter announces acquisition of Cheetah Medical to expand specialized patient monitoring
Baxter announced an agreement to acquire Cheetah Medical, a leading provider of non-invasive hemodynamic monitoring technologies. The transaction consists of an upfront cash consideration of $190 million, with potential for an additional $40 million based on clinical and commercial milestones. September 10, 2019